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Abstract Mammalian period genes have a pivotal role in
generating circadian rhythms and are rapidly induced by several
stimuli in mammalian cells. In the present study, we revealed
that treatment with thapsigargin significantly induced tran-
scripts of mouse period 1 and 2 (mPer1 and mPer2) but not
mPer3 among circadian related genes in NIH3T3 cells.
Thapsigargin-induced mPer1 and mPer2 mRNA expressions
took distinct signaling pathways from protein kinase C and
cAMP, but were partially inhibited by inhibitors of MEK1 and
p38 mitogen-activated protein kinase, respectively. Thus, the
present study suggested that intracellular calcium is one of
multiple signaling stimuli triggering mPer gene expression in
NIH3T3 cells. ß 2002 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Almost all organisms have endogenous biological rhythms
called circadian rhythms, that have an intrinsic period of ap-
proximately 24 h [1]. In mammals, the hypothalamic supra-
chiasmatic nucleus (SCN) is the center of circadian rhythms
such as sleep^wakefulness, glucose utilization and hormonal
rhythms [2]. The cycle time of the intrinsic circadian rhythm is
not precisely 24 h, and animals adjust their internal clocks to
local environmental day and night by periodic resetting. Light
is known as a strong regulator that causes a phase shift of the
clock, and this information is conveyed to the SCN neurons
directly via the retinohypothalamic tract (RHT) [3^5]. SCN
neurons show an intracellular Ca2 increase in response to
glutamate, a neurotransmitter in the RHT [6^8]. This in£ux
of Ca2 through ionotropic glutamate receptors is required
for clock resetting [9].
Three homologs of a Drosophila period gene (Per) and sev-
eral genes concerned with rhythm generation have been iden-
ti¢ed in mouse [10^13]. The molecular mechanisms of the
generating rhythms endogenously consist of positive and neg-
ative transcriptional feedback loops involving mPers, two
cryptochrome (Cry) and Clock genes [14,15]. Among them
mouse Per1 (mPer1) and Per2 (mPer2) were shown to be
induced in the SCN by light stimulation during night, and
were also considered essential for resetting the circadian clock
and shifting the ¢ring rhythm in the SCN [16^19].
Recently, several studies have reported that circadian genes
are expressed in both SCN and peripheral tissue [20,21]. Using
peripheral cells and cell lines, several stimuli such as high
concentrations of serum, forskolin, or phorbol 12-myristate
13-acetate (PMA) were reported to induce period genes [21^
23]. However, little is known about the precise e¡ects of the
intracellular calcium on the expression of these genes.
Here we show that the treatment of NIH3T3 cells with
thapsigargin, which elevates the intracellular calcium levels
by inhibiting endoplasmic reticulum Ca2-ATPase, induced
mPer1 and mPer2 genes among several circadian genes. More-
over, we suggest that this mPer1 mRNA induction by thap-
sigargin used a signaling pathway distinct from that by PMA
or forskolin induction.
2. Materials and methods
2.1. Materials
A speci¢c inhibitor of p38 mitogen-activated protein (MAP) kinase
(SB202190), a MAP kinase kinase (MEK1) inhibitor (U0126) and 1,2-
bis-(o-aminophenoxy)ethane-N,N,NP,NP-tetraacetic acid tetra-(acetox-
ymethyl)-ester (BAPTA-AM) were purchased from Calbiochem (La
Jolla, CA, USA). Forskolin and thapsigargin were obtained from
Seikagaku Co. Ltd. (Tokyo, Japan).
2.2. Cell culture and treatment
NIH3T3 cells were maintained with Dulbecco’s modi¢ed Eagle me-
dium (DMEM) (Gibco BRL) containing 10% fetal calf serum, 100 mg/
ml penicillin and 100 U/ml streptomycin. Before all experiments, cells
(3U105 cells/ml) were re-suspended in serum-free DMEM medium,
seeded to the plates and then used for the experiments. To induce
circadian genes, cells were treated with thapsigargin (0.5 WM), forsko-
lin (20 WM), or PMA (1 or 0.5 WM), respectively. The concentrations
of other drugs used were BAPTA-AM at 10 WM, U0126 at 40 or
10 WM and SB202190 at 10 or 2.5 WM.
2.3. Reverse transcriptional-polymerase chain reaction (RT-PCR)
To estimate the mRNA level of each circadian related gene by RT-
PCR, total RNA in the cells was extracted from lysed cells with Trizol
(Gibco BRL), and converted to cDNA by reverse transcriptase (RT)
using random hexamers to prime superscript II RNase-RT (Gibco
BRL) according to the manufacturer’s instructions. The reaction bu¡-
er contained 2.5 mM MgCl2, 0.5 mM dNTP mixture and 1 mM
dithiothreitol. Samples were incubated at 42‡C for 50 min and the
reaction was performed by heating at 70‡C for 15 min. Speci¢c DNAs
were mixed and ampli¢ed with PCR reaction mixture (Taq PCR core
0014-5793 / 02 / $22.00 ß 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 2 ) 0 2 5 1 0 - 3
*Corresponding author. Fax: (81)-75-251 5304.
E-mail address: mtanaka@basic.kpu-m.ac.jp (M. Tanaka).
Abbreviations: BAPTA-AM, 1,2-bis-(o-aminophenoxy)ethane-
N,N,NP,NP-tetraacetic acid tetra-(acetoxymethyl)-ester; CREB,
cAMP responsive element binding protein; Cry, cryptochrome; Erk,
extracellular signal-regulated kinase; MAP kinase, mitogen-activated
protein kinase; Per, period; PKC, protein kinase C; PMA, phorbol
12-myristate 13-acetate; SCN, suprachiasmatic nucleus
FEBS 25931 8-4-02
FEBS 25931 FEBS Letters 516 (2002) 101^105
kit, Qiagen), which contained 100 WM dNTP mixture, 1.5 mM MgCl2,
1.25 U Taq polymerase together with 0.2 WM of each primer and
cDNA. Each RT-PCR primer used in this study was as follows:
mPer1 sense primer, 5P-TGCTCTAGAAAGCTTATGAGTGGTCC-
CCTAGAAGG-3P ; mPer1 antisense primer, 5P-GCTCTAGATGG-
GCTCTGTGAGTTTGTAC-3P ; mPer2 sense primer, 5P-AATGGAT-
ACGTGGACTTCTC-3P ; mPer2 antisense primer, 5P-TGGCTCTCA-
CTGGACATTAG-3P ; mPer3 sense primer, 5P-TGCTGAGGAGAA-
AAGTGCCC-3P ; mPer3 antisense primer, 5P-AGACATTCTGTTTC-
GGTCTTCG-3P ; DBP sense primer, 5P-CTCATCTCTTCGACTCT-
CCA-3P ; DBP antisense primer, 5P-TCCAGGTCCACGTATTCCAC-
3P ; Clock sense primer, 5P-CTTCCTGGTAACGCGAGAAA-3P ;
Clock antisense primer, 5P-TTTCCAGCAGATGAGTAGAG-3P ;
Cry1 sense primer, 5P-GAGAGAATGTCCCGAGTTGT-3P ; Cry1
antisense primer, 5P-TTACTGCTCTGCCGCTGGAC-3P ; Cry2 sense
primer, 5P-GAGGTGGTGACTGAGAACT-3P ; Cry2 antisense prim-
er, 5P-CAAGTCCCACAGGCGGTAGT-3P ; G3PDH sense primer,
5P-TCCACCACCCTGTTGCTGTA-3P ; and G3PDH antisense prim-
er, 5P-ACCACAGTCCATGCCATCAC-3P. The typical reaction con-
ditions were 0.5 min at 95‡C, 0.5 min at 60‡C, and 1 min at 72‡C. The
results represent 18^30 cycles of ampli¢cation, after which cDNAs
were separated by electrophoresis on 2.0% agarose gels and visualized
using ethidium bromide. Experiments were repeated at least twice and
reproducibility was con¢rmed.
2.4. Immunoblot analysis
Phosphorylated extracellular signal-regulated kinase (Erk), p38
MAP kinase and cAMP responsive element binding protein (CREB)
were analyzed by immunoblotting. Cells treated with thapsigargin or
forskolin were lysed with 20 mM Tris bu¡er, pH 8.0, containing 137
mM NaCl, 2 mM EDTA, 10% (v/v) glycerol, 1 mM phenylmethylsul-
fonyl £uoride, 10 Wg/ml leupeptin, 10 Wg/ml aprotinin, 1 mM sodium
vanadate and 1% (v/v) Triton X-100. The protein concentration was
determined by the method of Bradford [24]. Cell lysate containing 40
Wg protein was separated on 8.0% SDS^polyacrylamide electrophore-
sis gels, immunoblotted onto polyvinylidene di£uoride membrane
(Millipore, Bedford, MA, USA) and identi¢ed by enhanced chemilu-
minescence using antibodies against phosphorylated p38, Erk and
CREB. After immunoblotting, electrophoresis gels were stained with
Coomassie blue stain to con¢rm the protein level of each lane.
3. Results
3.1. Thapsigargin induced mPer1 and mPer2 mRNA in
NIH3T3 cells
We investigated by RT-PCR whether intracellular calcium
level a¡ects circadian gene expression. Stimulation of the
NIH3T3 cells with thapsigargin strongly induced mPer1 and
mPer2 mRNA expression among circadian genes (Fig. 1a,b).
The level of thapsigargin-induced mPer1 and mPer2 mRNA
reached a peak within 1^4 h and declined to basal levels
before 8 h, but mPer3 was less responsive. In other circadian
related genes, the levels of DBP mRNA were constitutively
low and decreased further in response to thapsigargin. Clock
mRNA, a positive transcriptional regulator of mPer1, was
hardly a¡ected by thapsigargin. On the other hand, Cry1
and Cry2 mRNA, known as negative regulators of mPer1,
were induced 4^8 h after thapsigargin treatment (Fig. 1a,c).
Expressions of these genes were weak and did not £uctuate
without thapsigargin treatment.
Compared with other stimuli, which have been reported to
a¡ect circadian genes such as PMA and forskolin, thapsigar-
gin induced mPer1 mRNA in NIH3T3 cells to the same extent
(data not shown). To test whether intracellular calcium a¡ects
mPer1 expression by PMA or forskolin, we measured the
expression of mPer1 in NIH3T3 cells in the presence of BAP-
TA-AM, a cell permeable intracellular calcium chelator.
Although forskolin or PMA alone induced mPer1 mRNA
and co-stimulation markedly augmented its expression, treat-
ment with BAPTA-AM reduced mPer1 mRNA expression to
basal levels (Fig. 2).
Fig. 1. Thapsigargin a¡ects circadian related gene expression in NIH3T3 cells. NIH3T3 cells were exposed to thapsigargin at 0.5 WM for the in-
dicated time (a). Cells were treated with vehicle (Con) or thapsigargin (TG, 0.5 WM) to detect mPer1 and mPer2 mRNA for 0 or 1.5 h (b), or
Cry1 and Cry2 mRNA for 0 or 4 h (c). Total RNA was isolated from cells and each mRNA was analyzed by RT-PCR as described in Section
2.
Fig. 2. BAPTA-AM suppresses PMA- and forskolin-induced mPer1
mRNA expression in NIH3T3 cells. After 1 h pretreatment with
BAPTA-AM (10 WM) or vehicle, cells were treated with PMA (0.5
WM) and/or forskolin (20 WM) for 60 min. Total RNA was isolated
from cells and each mRNA was analyzed by RT-PCR as described
in Section 2.
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3.2. Protein kinase C (PKC) and cAMP signaling did not
contribute to thapsigargin-induced mPer1 and mPer2
mRNA in NIH3T3 cells
Next, we investigated whether PKC activation and/or in-
crease in cAMP levels are downstream signaling of intracel-
lular calcium mobilization by thapsigargin. Since prolonged
exposure with PMA down-regulates PKC activities in several
cells, we measured thapsigargin-induced mPer1 and mPer2
mRNA in NIH3T3 cells 24 h after treatment with PMA at
1 WM. The basal level of mPer1 and mPer2 mRNA was
slightly reduced compared with unexposed cells. Thapsigargin
signi¢cantly induced mPer1 and mPer2 mRNA within 1 h
although retreatment with PMA at 0.5 WM did not induce
mPer1 and mPer2 mRNA (Fig. 3). We measured the phos-
phorylation status of CREB, one of the downstreams of the
cAMP pathway, to elucidate the role of cAMP on thapsigar-
gin-induced mPer1 mRNA. Treatment with forskolin imme-
diately induced phosphorylated CREB and maintained its
phosphorylation for more than 40 min. However, thapsigar-
gin hardly augmented CREB phosphorylation in the present
study conditions (Fig. 4).
3.3. MAP kinase inhibitors down-regulated thapsigargin-
induced mPer1 mRNA in NIH3T3 cells
We also studied the e¡ects of MAP kinase on thapsigargin-
induced mPer1 and mPer2 mRNA expression using U0126
and SB202190 (Fig. 5). As shown in Fig. 4, thapsigargin im-
mediately induced p38 MAP kinase phosphorylation and
maintained its status until 40 min. Forskolin induced p38
MAP kinase phosphorylation only transiently although
CREB was continuously phosphorylated. The phosphoryla-
tion status of Erk was basically high in our study conditions
compared with that of p38 MAP kinase, and its phosphory-
lation was maintained by the treatment with thapsigargin.
On the other hand, forskolin continuously declined Erk
phosphorylation in NIH3T3 cells. U0126 at 10 WM and
SB202190 at 2.5 WM partially reduced thapsigargin-induced
mPer1 mRNA expression. Similar e¡ects of both reagents
on thapsigargin-induced mPer2 mRNA expression were also
detected (data not shown).
4. Discussion
Calcium-dependent gene expression regulates fundamental
biological responses including cell survival, di¡erentiation and
proliferation. Thapsigargin, a non-phorbol ester-type tumor
promoter, discharges intracellular Ca2 stores by speci¢c in-
hibition of the endoplasmic reticulum Ca2-ATPase [25]. In
the present study, we demonstrated that thapsigargin-depen-
dent calcium mobilization transiently induced mPer1 and
mPer2, among circadian oscillatory genes, in NIH3T3 cells.
Of the three period genes, mPer1 mRNA tended to be the
most sensitive to thapsigargin, but the induction of mPer3
mRNA was only marginal. Recently, di¡erent functions,
and the regulation, of the three period genes for the circadian
Fig. 3. E¡ect of PKC down-regulation on thapsigargin-induced
mPer1 and mPer2 mRNA expression in NIH3T3 cells. After 24 h
pretreatment with PMA (PMA-24 h, 1 WM) or vehicle, cells were
treated with PMA (0.5 WM) or thapsigargin (TG, 0.5 WM) for 60
min. Total RNA was isolated from cells and each mRNA was ana-
lyzed by RT-PCR as described in Section 2.
Fig. 4. Thapsigargin and forskolin a¡ect the phosphorylation of
Erk, p38 MAP kinase and CREB in NIH3T3 cells. The cells were
incubated with forskolin (20 WM) or thapsigargin (TG) (0.5 WM) for
the indicated time. Cell lysate was analyzed by immunoblotting with
antibodies against phosphorylated Erk, p38 kinase and CREB as
described in Section 2.
Fig. 5. E¡ect of U0126 and SB202190 on mPer1 mRNA expression
in NIH3T3 cells. After 1 h pretreatment with U0126 (40 or 10 WM),
SB202190 (SB, 10 or 2.5 WM) or vehicle, cells were treated with
thapsigargin (TG) at 0.5 WM for 60 min. Total RNA was isolated
from cells and each mRNA was analyzed by RT-PCR as described
in Section 2 (a). The relative mRNA level of mPer1 was calculated
by comparison of G3PDH-normalized values with the levels of un-
treated controls (b).
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clock in mutant mice were reported [26,27]. Intracellular cal-
cium may regulate each period gene by distinct mechanisms.
We could also detect other circadian related genes including
Clock, DBP, Cry1 and Cry2 by thapsigargin. The e¡ects of
thapsigargin on each gene expression were varied. We ob-
served that Cry1 and Cry2 mRNA were induced in response
to intracellular calcium mobilization for the ¢rst time, and
they were induced later than mPer1 or mPer2. Cry has been
reported to negatively regulate period gene transcription
[14,15]. Therefore, the induction of Cry mRNA may be a
consequence of the immediate induction of mPer1 and
mPer2 mRNA. In contrast to the enhancement of the expres-
sion of mPer and mCry genes, the expression of DBP mRNA
was reduced in NIH3T3 cells by treatment with thapsigargin.
The present results agree with results that endothelin-1-depen-
dent mPer induction is accompanied with the reduction of
DBP mRNA [28], but the precise mechanisms remain to be
determined.
Recently, it was reported that cells in peripheral tissues also
have circadian clock genes similar to the SCN, the central
clock in mammals. Balsalobre et al. ¢rst reported that treat-
ment with high concentrations of horse serum (serum shock)
induced circadian genes such as rPer1, rPer2 and DBP in
addition to immediate early genes in rat-1 ¢broblast [21]. In
addition to serum shock, many stimuli such as forskolin, glu-
cocorticoid, and PMA have been reported to induce circadian
genes in cell line models [21^23,29]. We demonstrated that an
intracellular calcium chelator, BAPTA-AM, reduced forskolin
and/or PMA-induced mPer1 mRNA expression to basal lev-
els. Therefore, we next investigated the contribution of the
cAMP- and PKC-mediated pathways to thapsigargin-induced
mPer1 and mPer2 mRNA expression in NIH3T3 cells. The
forskolin-dependent phosphorylation status of Erk, p38 MAP
kinase and CREB was signi¢cantly di¡erent from thapsigar-
gin-dependent ones. PMA is a strong activator of PKC but
prolonged treatment with PMA down-regulates PKC signal-
ing [30]. In the present study conditions, thapsigargin still
induced mPer1 and mPer2 mRNA after prolonged treatment
with PMA although they abolished PMA-dependent mPer1
and mPer2 mRNA expression. From these ¢ndings, protein
kinase A and PKC appeared to have a minor role in thapsi-
gargin-induced mPer1 and mPer2 mRNA in NIH3T3 cells.
MAP kinases are subdivided into Erk, p38 MAP kinase or
c-JUN amino-terminal protein kinase. Speci¢c pharmacolog-
ical inhibitors such as U0126 for MEK1-Erk and SB202190
for p38 MAP kinase were utilized to demonstrate the involve-
ment of each kinase in various cellular events [31^33]. In the
study conditions, phosphorylation of Erk was still high under
resting conditions and thapsigargin predominantly induced
phosphorylation of p38 MAP kinase. Both inhibitors partially
but signi¢cantly prevented thapsigargin-induced mPer1 and
mPer2 mRNA expression in NIH3T3 cells. These results are
consistent with the inhibitory e¡ects of both reagents for
thapsigargin-dependent histidine decarboxylase expression in
RAW cells [34]. However, the limited e¡ects of both inhibitors
suggest that additional signaling pathways contributed to the
thapsigargin-induced mPer1 and mPer2 mRNA expression in
NIH3T3 cells. Very recently, a pharmacological inhibitor spe-
ci¢c for Ca2/calmodulin-dependent kinase was reported to be
involved in Per1 induction in hamster SCN, although its con-
tribution to the thapsigargin-mediated signaling pathway re-
mains to be determined [35].
In conclusion, the ¢ndings here demonstrated that mPer1
and mPer2 mRNA, among several circadian related genes in
NIH3T3 cells, are rapidly induced by intracellular calcium
mobilization via the MAP kinase pathway. This Ca2 in-
crease^MAP kinase pathway, distinct from pathways such
as PMA^MAP kinase and forskolin-phosphorylated CREB,
may also be involved in the resetting of the circadian clock
rhythm. Further studies about the downstream signaling path-
ways of MAP kinase will give new insights into the molecular
mechanisms of the mammalian circadian clock.
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